35265-06-6

Usage

Uses

Used in Pharmaceutical Industry:
2-(Cyclopropylamino)ethanol is used as a pharmaceutical intermediate for the synthesis of various medicinal compounds. Its cyclopropyl group and secondary amine functionality make it a valuable building block in the development of new drugs, potentially contributing to the creation of novel therapeutic agents.
Used in Chemical Research:
In the field of chemical research, 2-(Cyclopropylamino)ethanol serves as a subject of study for understanding the reactivity and properties of cyclopropylamines. Its unique structure allows researchers to explore new reaction pathways and mechanisms, potentially leading to the discovery of innovative synthetic methods and applications in organic chemistry.
Used in Industrial Applications:
2-(Cyclopropylamino)ethanol is utilized in various industrial applications due to its chemical properties. Its versatility as a secondary amine and the presence of the cyclopropyl group make it suitable for use in the synthesis of specialty chemicals, materials, and other products that require specific functional groups or structural features.

Upstream product

• 4755-77-5 Ethyl oxalyl chloride 
• 765-30-0 Cyclopropylamine 
• 540-51-2 2-bromoethanol 
• 722486-66-0 2-(cyclopropylamino)-2-oxoacetic acid ethyl ester 

Downstream Products

• 918633-67-7 N-cyclopropyl-2-chloroethylamine hydrochloride 
• 1190970-38-7 2-chloro-N-cyclopropyl-N-[2-[2-[2-[(3,3-difluoro-azetidin-1-yl)-methyl]-4,5,6,7-tetrahydro-thieno[3,2-c]pyridin-5-yl]-2-oxo-ethoxy]-ethyl]-6-methyl-benzenesulfonic acid amide 
• 1190970-37-6 N-[2-[2-[2-(azetidin-1-yl-methyl)-4,5,6,7-tetrahydro-thieno[3,2-c]pyridin-5-yl]-2-oxo-ethoxy]-ethyl]-2-chloro-N-cyclopropyl-6-methyl-benzenesulfonic acid amide 
• 1190971-05-1 tert-butyl 2-(2-(2-chloro-N-cyclopropyl-6-methyl-phenylsulfonylamino)ethoxy)acetate 
• 1186240-93-6 2-(2-(2-chloro-N-cyclopropyl-6-methylphenylsulfonamido)ethoxy)acetic acid 
• 1186240-80-1 N-cyclopropyl-N-(2-(2-(4-(4-cyclopropylpiperazin-1-yl)-4-((1-oxoisoindolin-2-yl)methyl)piperidin-1-yl)-2-oxoethoxy)ethyl)-4-methoxy-2,6-dimethylbenzenesulfonamide 
• 1186240-82-3 N-((1-(2-(2-(N-cyclopropyl-4-methoxy-2,6-dimethylphenylsulfonamido)ethoxy)acetyl)-4-(4-cyclopropylpiperazin-1-yl)piperidin-4-yl)methyl)isonicotinamide 
• 1186240-84-5 N-((1-(2-(2-(N-cyclopropyl-4-methoxy-2,6-dimethylphenylsulfonamido)ethoxy)acetyl)-4-(4-(pyridin-4-yl)piperazin-1-yl)piperidin-4-yl)methyl)acetamide 
• 775287-76-8 [2-[cyclopropyl[(4-methoxy-2,6-dimethylphenyl)sulphonyl]amino]ethoxy]acetic acid,1,1-dimethylethyl ester 
• 775287-75-7 N-cyclopropyl-N-(2-hydroxyethyl)-4-methoxy-2,6-dimethylbenzene-sulphonamide 
• 1190971-04-0 2-chloro-N-cyclopropyl-N-(2-hydroxyethyl)-6-methyl-benzenesulfonamide 

Relevant academic research and scientific papers

LIPID NANOPARTICLE COMPOSITION

Provided herein are lipids that can be used in combination with other lipid components, such as neutral lipids, cholesterol and polymer conjugated lipids, to form lipid nanoparticles for delivery of therapeutic agents (e.g., nucleic acid molecules) for therapeutic or prophylactic purposes, including vaccination.

MICROBIOCIDAL OXADIAZOLE DERIVATIVES

Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as pesticides, especially as fungicides.

Substituted Spiroamine Compounds

Substituted spiroamine compounds corresponding to the formula (I) In which m, n, o, p, Q, r, s, t, R1, R2, R3, R4a, R4b, R5a, R5b, R6a, R6b, R7, R8, R9, R10 and R11 have defined meanings; a process for the preparation of such compounds, pharmaceutical compositions containing such compounds and the use of substituted spiroamines for the treatment or inhibition of pain and/or other conditions mediated by the bradykinin 1 receptor.

Substituted Sulfonamide Compounds

Substituted sulfonamide compounds corresponding to formula I: a process for their preparation, pharmaceutical compositions comprising such compounds, and the use of such substituted sulfonamide compounds in pharmaceutical compositions for the treatment of pain or other disorders or diseases that are mediated at least in part by B1R receptors.

SUBSTITUTED SULFONAMIDE COMPOUNDS

Substituted sulfonamide compounds corresponding to formula I processes for the preparation thereof, pharmaceutical compositions containing these compounds, and the use of such substituted sulfonamide compounds in pharmaceutical compositions for the treatment and/or inhibition of pain and other conditions at least partly mediated by the bradykinin 1 receptor

SUBSTITUTED SULFONAMIDE DERIVATIVES

The invention relates to substituted sulfonamide derivatives, processes for the preparation thereof, medicaments containing these compounds and the use of substituted sulfonamide derivatives for the preparation of medicaments.

SUBSTITUTED SULFONAMIDE DERIVATIVES

The invention relates to substituted sulfonamide derivatives, processes for the preparation thereof, medicaments containing these compounds and the use of substituted sulfonamide derivatives for the preparation of medicaments.

PHOSPHORAMIDATE ALKYLATOR PRODRUGS

Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.